CA2554623A1

CA2554623A1 - Nouveaux nucleotides et sequences d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du colon

Nouveaux nucleotides et sequences d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du colon Download PDF

Info

Publication number: CA2554623A1
Authority: CA; Canada
Prior art keywords: seq; amino acid; amino acids; acid sequence; homologous
Prior art date: 2004-01-27
Legal status : Abandoned

Application number

CA002554623A

Other languages

English (en)

Inventor

Rotem Sorek

Michal Ayalon-Soffer

Dvir Dahary

Amit Novik

Amir Toporik

Alexander Diber

Guy Kol

Sarah Pollock

Zurit Levine

Gad S. Cojocaru

Ronen Shemesh

Yossi Cohen

Osnat Sella-Tavor

Shirley Sameah-Greenwald

Shira Walach

Current Assignee

Compugen Ltd

Original Assignee

Individual

Priority date

2004-01-27

Filing date

2005-01-27

Publication date

2005-08-11

2005-01-27 Application filed by Individual filed Critical Individual

2005-01-27 Priority claimed from PCT/IB2005/000928 external-priority patent/WO2005072053A2/fr

2005-08-11 Publication of CA2554623A1 publication Critical patent/CA2554623A1/fr

Status Abandoned legal-status Critical Current

Links

206010009944 Colon cancer Diseases 0.000 title claims abstract description 104
208000029742 colonic neoplasm Diseases 0.000 title claims abstract description 94
238000000034 method Methods 0.000 title claims description 53
125000003275 alpha amino acid group Chemical group 0.000 title claims 7
238000003745 diagnosis Methods 0.000 title abstract description 11
238000003556 assay Methods 0.000 title description 23
239000002773 nucleotide Substances 0.000 title description 20
125000003729 nucleotide group Chemical group 0.000 title description 19
238000001514 detection method Methods 0.000 claims abstract description 11
150000001413 amino acids Chemical class 0.000 claims description 2180
108090000765 processed proteins & peptides Proteins 0.000 claims description 925
102000004196 processed proteins & peptides Human genes 0.000 claims description 919
229920001184 polypeptide Polymers 0.000 claims description 917
102000040430 polynucleotide Human genes 0.000 claims description 75
108091033319 polynucleotide Proteins 0.000 claims description 75
239000002157 polynucleotide Substances 0.000 claims description 75
150000007523 nucleic acids Chemical group 0.000 claims description 73
108090000623 proteins and genes Proteins 0.000 claims description 59
102000004169 proteins and genes Human genes 0.000 claims description 52
230000002018 overexpression Effects 0.000 claims description 47
108091093088 Amplicon Proteins 0.000 claims description 46
108091034117 Oligonucleotide Proteins 0.000 claims description 36
108091028043 Nucleic acid sequence Proteins 0.000 claims description 34
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 17
239000000090 biomarker Substances 0.000 claims description 17
239000012634 fragment Substances 0.000 claims description 17
238000003018 immunoassay Methods 0.000 claims description 12
238000009739 binding Methods 0.000 claims description 11
230000027455 binding Effects 0.000 claims description 10
238000005516 engineering process Methods 0.000 claims description 10
238000012544 monitoring process Methods 0.000 claims description 9
238000012216 screening Methods 0.000 claims description 7
238000002560 therapeutic procedure Methods 0.000 claims description 7
238000002965 ELISA Methods 0.000 claims description 6
239000003153 chemical reaction reagent Substances 0.000 claims description 6
238000011282 treatment Methods 0.000 claims description 6
206010061818 Disease progression Diseases 0.000 claims description 4
230000005750 disease progression Effects 0.000 claims description 4
238000001262 western blot Methods 0.000 claims description 3
210000001072 colon Anatomy 0.000 abstract description 58
238000005259 measurement Methods 0.000 abstract description 4
239000013610 patient sample Substances 0.000 abstract description 3
229940024606 amino acid Drugs 0.000 description 1223
230000000875 corresponding effect Effects 0.000 description 342
210000001519 tissue Anatomy 0.000 description 106
241000282414 Homo sapiens Species 0.000 description 97
201000011510 cancer Diseases 0.000 description 91
230000014509 gene expression Effects 0.000 description 84
206010028980 Neoplasm Diseases 0.000 description 77
101100012019 Mus musculus Etv4 gene Proteins 0.000 description 73
239000000523 sample Substances 0.000 description 29
239000003550 marker Substances 0.000 description 27
208000001333 Colorectal Neoplasms Diseases 0.000 description 22
210000004027 cell Anatomy 0.000 description 21
102000039446 nucleic acids Human genes 0.000 description 20
108020004707 nucleic acids Proteins 0.000 description 20
239000000203 mixture Substances 0.000 description 19
239000002253 acid Substances 0.000 description 15
150000007513 acids Chemical class 0.000 description 14
239000012472 biological sample Substances 0.000 description 14
238000003780 insertion Methods 0.000 description 13
230000037431 insertion Effects 0.000 description 13
210000001165 lymph node Anatomy 0.000 description 13
201000010099 disease Diseases 0.000 description 12
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
238000002493 microarray Methods 0.000 description 11
102100039813 Inactive tyrosine-protein kinase 7 Human genes 0.000 description 10
206010027476 Metastases Diseases 0.000 description 10
210000004556 brain Anatomy 0.000 description 10
-1 for all transcripts) Proteins 0.000 description 10
230000009401 metastasis Effects 0.000 description 10
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 10
238000012360 testing method Methods 0.000 description 10
102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 9
101710099452 Inactive tyrosine-protein kinase 7 Proteins 0.000 description 9
102220521910 THAP domain-containing protein 1_S21C_mutation Human genes 0.000 description 9
101000617818 Homo sapiens Solute carrier organic anion transporter family member 4A1 Proteins 0.000 description 8
101710202677 Non-specific lipid-transfer protein Proteins 0.000 description 8
102100022428 Phospholipid transfer protein Human genes 0.000 description 8
102100022004 Solute carrier organic anion transporter family member 4A1 Human genes 0.000 description 8
230000000295 complement effect Effects 0.000 description 8
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 8
230000004083 survival effect Effects 0.000 description 8
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 7
230000009545 invasion Effects 0.000 description 7
230000003211 malignant effect Effects 0.000 description 7
230000007170 pathology Effects 0.000 description 7
108010022366 Carcinoembryonic Antigen Proteins 0.000 description 6
208000028952 Chronic enteropathy associated with SLCO2A1 gene Diseases 0.000 description 6
208000037062 Polyps Diseases 0.000 description 6
238000000525 cavity enhanced absorption spectroscopy Methods 0.000 description 6
238000002052 colonoscopy Methods 0.000 description 6
230000004048 modification Effects 0.000 description 6
238000012986 modification Methods 0.000 description 6
230000001575 pathological effect Effects 0.000 description 6
101710084357 Fibroblast growth factor receptor-like 1 Proteins 0.000 description 5
102100026149 Fibroblast growth factor receptor-like 1 Human genes 0.000 description 5
102100032420 Protein S100-A9 Human genes 0.000 description 5
102100032724 SPARC-related modular calcium-binding protein 2 Human genes 0.000 description 5
208000021045 exocrine pancreatic carcinoma Diseases 0.000 description 5
238000009396 hybridization Methods 0.000 description 5
210000004185 liver Anatomy 0.000 description 5
230000035772 mutation Effects 0.000 description 5
238000011330 nucleic acid test Methods 0.000 description 5
208000008443 pancreatic carcinoma Diseases 0.000 description 5
239000013615 primer Substances 0.000 description 5
238000004393 prognosis Methods 0.000 description 5
210000000664 rectum Anatomy 0.000 description 5
102000053602 DNA Human genes 0.000 description 4
108020004414 DNA Proteins 0.000 description 4
241000792859 Enema Species 0.000 description 4
102000016621 Focal Adhesion Protein-Tyrosine Kinases Human genes 0.000 description 4
108010067715 Focal Adhesion Protein-Tyrosine Kinases Proteins 0.000 description 4
101000708790 Homo sapiens SPARC-related modular calcium-binding protein 2 Proteins 0.000 description 4
101000577877 Homo sapiens Stromelysin-3 Proteins 0.000 description 4
101800001987 Seminal basic protein Proteins 0.000 description 4
102400000868 Seminal basic protein Human genes 0.000 description 4
102100028847 Stromelysin-3 Human genes 0.000 description 4
108091032917 Transfer-messenger RNA Proteins 0.000 description 4
125000000217 alkyl group Chemical group 0.000 description 4
238000001574 biopsy Methods 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
208000029664 classic familial adenomatous polyposis Diseases 0.000 description 4
229940104302 cytosine Drugs 0.000 description 4
238000002405 diagnostic procedure Methods 0.000 description 4
239000007920 enema Substances 0.000 description 4
229940095399 enema Drugs 0.000 description 4
210000004072 lung Anatomy 0.000 description 4
210000000056 organ Anatomy 0.000 description 4
230000001105 regulatory effect Effects 0.000 description 4
238000006467 substitution reaction Methods 0.000 description 4
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
229930024421 Adenine Natural products 0.000 description 3
208000004804 Adenomatous Polyps Diseases 0.000 description 3
101100203496 Arabidopsis thaliana SMO2-1 gene Proteins 0.000 description 3
101100312823 Arabidopsis thaliana TRM112A gene Proteins 0.000 description 3
101710190849 Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
201000006107 Familial adenomatous polyposis Diseases 0.000 description 3
208000017095 Hereditary nonpolyposis colon cancer Diseases 0.000 description 3
108020005187 Oligonucleotide Probes Proteins 0.000 description 3
108091093037 Peptide nucleic acid Proteins 0.000 description 3
108010076504 Protein Sorting Signals Proteins 0.000 description 3
229910021183 SMO2 Inorganic materials 0.000 description 3
101710202247 SPARC-related modular calcium-binding protein 2 Proteins 0.000 description 3
108700025716 Tumor Suppressor Genes Proteins 0.000 description 3
102000044209 Tumor Suppressor Genes Human genes 0.000 description 3
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 3
230000005856 abnormality Effects 0.000 description 3
229960000643 adenine Drugs 0.000 description 3
208000009956 adenocarcinoma Diseases 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
239000000427 antigen Substances 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
230000006907 apoptotic process Effects 0.000 description 3
238000003491 array Methods 0.000 description 3
229910052788 barium Inorganic materials 0.000 description 3
DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000000988 bone and bone Anatomy 0.000 description 3
239000002131 composite material Substances 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
210000003734 kidney Anatomy 0.000 description 3
230000036210 malignancy Effects 0.000 description 3
210000004400 mucous membrane Anatomy 0.000 description 3
238000013188 needle biopsy Methods 0.000 description 3
239000002777 nucleoside Substances 0.000 description 3
239000002751 oligonucleotide probe Substances 0.000 description 3
239000003415 peat Substances 0.000 description 3
239000002243 precursor Substances 0.000 description 3
239000000047 product Substances 0.000 description 3
238000011160 research Methods 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
238000002579 sigmoidoscopy Methods 0.000 description 3
230000019491 signal transduction Effects 0.000 description 3
238000001356 surgical procedure Methods 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
229940035893 uracil Drugs 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
FZWGECJQACGGTI-UHFFFAOYSA-N 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one Chemical compound NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 2
OVONXEQGWXGFJD-UHFFFAOYSA-N 4-sulfanylidene-1h-pyrimidin-2-one Chemical compound SC=1C=CNC(=O)N=1 OVONXEQGWXGFJD-UHFFFAOYSA-N 0.000 description 2
UJBCLAXPPIDQEE-UHFFFAOYSA-N 5-prop-1-ynyl-1h-pyrimidine-2,4-dione Chemical compound CC#CC1=CNC(=O)NC1=O UJBCLAXPPIDQEE-UHFFFAOYSA-N 0.000 description 2
PEHVGBZKEYRQSX-UHFFFAOYSA-N 7-deaza-adenine Chemical compound NC1=NC=NC2=C1C=CN2 PEHVGBZKEYRQSX-UHFFFAOYSA-N 0.000 description 2
HCGHYQLFMPXSDU-UHFFFAOYSA-N 7-methyladenine Chemical compound C1=NC(N)=C2N(C)C=NC2=N1 HCGHYQLFMPXSDU-UHFFFAOYSA-N 0.000 description 2
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
102000005234 Adenosylhomocysteinase Human genes 0.000 description 2
108020002202 Adenosylhomocysteinase Proteins 0.000 description 2
108091026890 Coding region Proteins 0.000 description 2
108700010070 Codon Usage Proteins 0.000 description 2
102100031968 Ephrin type-B receptor 2 Human genes 0.000 description 2
101710114534 Ephrin type-B receptor 2 Proteins 0.000 description 2
108091060211 Expressed sequence tag Proteins 0.000 description 2
102100026406 G/T mismatch-specific thymine DNA glycosylase Human genes 0.000 description 2
101710113436 GTPase KRas Proteins 0.000 description 2
208000008051 Hereditary Nonpolyposis Colorectal Neoplasms Diseases 0.000 description 2
101000912518 Homo sapiens Fibroblast growth factor receptor-like 1 Proteins 0.000 description 2
101000606548 Homo sapiens Receptor-type tyrosine-protein phosphatase gamma Proteins 0.000 description 2
201000005027 Lynch syndrome Diseases 0.000 description 2
101710135898 Myc proto-oncogene protein Proteins 0.000 description 2
102100038895 Myc proto-oncogene protein Human genes 0.000 description 2
108010038807 Oligopeptides Proteins 0.000 description 2
102000015636 Oligopeptides Human genes 0.000 description 2
108700020796 Oncogene Proteins 0.000 description 2
206010033128 Ovarian cancer Diseases 0.000 description 2
108010067372 Pancreatic elastase Proteins 0.000 description 2
102000016387 Pancreatic elastase Human genes 0.000 description 2
ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
239000004698 Polyethylene Substances 0.000 description 2
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
102100039661 Receptor-type tyrosine-protein phosphatase gamma Human genes 0.000 description 2
208000015634 Rectal Neoplasms Diseases 0.000 description 2
238000012300 Sequence Analysis Methods 0.000 description 2
RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 2
108010035344 Thymine DNA Glycosylase Proteins 0.000 description 2
101710150448 Transcriptional regulator Myc Proteins 0.000 description 2
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
230000004913 activation Effects 0.000 description 2
239000011324 bead Substances 0.000 description 2
230000008901 benefit Effects 0.000 description 2
238000009534 blood test Methods 0.000 description 2
210000001185 bone marrow Anatomy 0.000 description 2
208000002458 carcinoid tumor Diseases 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
230000030570 cellular localization Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
238000002512 chemotherapy Methods 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical group C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
230000034994 death Effects 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
238000013399 early diagnosis Methods 0.000 description 2
230000002550 fecal effect Effects 0.000 description 2
239000012530 fluid Substances 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
230000037433 frameshift Effects 0.000 description 2
206010017758 gastric cancer Diseases 0.000 description 2
208000010749 gastric carcinoma Diseases 0.000 description 2
230000000762 glandular Effects 0.000 description 2
230000012010 growth Effects 0.000 description 2
125000001475 halogen functional group Chemical group 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
238000007689 inspection Methods 0.000 description 2
102000006495 integrins Human genes 0.000 description 2
108010044426 integrins Proteins 0.000 description 2
230000003993 interaction Effects 0.000 description 2
230000000968 intestinal effect Effects 0.000 description 2
210000002429 large intestine Anatomy 0.000 description 2
230000003902 lesion Effects 0.000 description 2
230000004807 localization Effects 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000000463 material Substances 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
230000001394 metastastic effect Effects 0.000 description 2
206010061289 metastatic neoplasm Diseases 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
230000009826 neoplastic cell growth Effects 0.000 description 2
150000003833 nucleoside derivatives Chemical class 0.000 description 2
125000003835 nucleoside group Chemical group 0.000 description 2
238000002515 oligonucleotide synthesis Methods 0.000 description 2
210000000496 pancreas Anatomy 0.000 description 2
230000035515 penetration Effects 0.000 description 2
125000004437 phosphorous atom Chemical group 0.000 description 2
229910052698 phosphorus Inorganic materials 0.000 description 2
230000026447 protein localization Effects 0.000 description 2
150000003212 purines Chemical class 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
229920002477 rna polymer Polymers 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
238000010532 solid phase synthesis reaction Methods 0.000 description 2
241000894007 species Species 0.000 description 2
230000009870 specific binding Effects 0.000 description 2
210000002784 stomach Anatomy 0.000 description 2
201000000498 stomach carcinoma Diseases 0.000 description 2
239000000126 substance Substances 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
210000004876 tela submucosa Anatomy 0.000 description 2
229940113082 thymine Drugs 0.000 description 2
210000001685 thyroid gland Anatomy 0.000 description 2
210000002700 urine Anatomy 0.000 description 2
210000004291 uterus Anatomy 0.000 description 2
BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
QGVQZRDQPDLHHV-DPAQBDIFSA-N (3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene-3-thiol Chemical compound C1C=C2C[C@@H](S)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 QGVQZRDQPDLHHV-DPAQBDIFSA-N 0.000 description 1
FYADHXFMURLYQI-UHFFFAOYSA-N 1,2,4-triazine Chemical class C1=CN=NC=N1 FYADHXFMURLYQI-UHFFFAOYSA-N 0.000 description 1
UHUHBFMZVCOEOV-UHFFFAOYSA-N 1h-imidazo[4,5-c]pyridin-4-amine Chemical compound NC1=NC=CC2=C1N=CN2 UHUHBFMZVCOEOV-UHFFFAOYSA-N 0.000 description 1
QSHACTSJHMKXTE-UHFFFAOYSA-N 2-(2-aminopropyl)-7h-purin-6-amine Chemical compound CC(N)CC1=NC(N)=C2NC=NC2=N1 QSHACTSJHMKXTE-UHFFFAOYSA-N 0.000 description 1
GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
KMEMIMRPZGDOMG-UHFFFAOYSA-N 2-cyanoethoxyphosphonamidous acid Chemical compound NP(O)OCCC#N KMEMIMRPZGDOMG-UHFFFAOYSA-N 0.000 description 1
LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 description 1
ZLAQATDNGLKIEV-UHFFFAOYSA-N 5-methyl-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound CC1=CNC(=S)NC1=O ZLAQATDNGLKIEV-UHFFFAOYSA-N 0.000 description 1
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical group CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
KXBCLNRMQPRVTP-UHFFFAOYSA-N 6-amino-1,5-dihydroimidazo[4,5-c]pyridin-4-one Chemical compound O=C1NC(N)=CC2=C1N=CN2 KXBCLNRMQPRVTP-UHFFFAOYSA-N 0.000 description 1
DCPSTSVLRXOYGS-UHFFFAOYSA-N 6-amino-1h-pyrimidine-2-thione Chemical compound NC1=CC=NC(S)=N1 DCPSTSVLRXOYGS-UHFFFAOYSA-N 0.000 description 1
QNNARSZPGNJZIX-UHFFFAOYSA-N 6-amino-5-prop-1-ynyl-1h-pyrimidin-2-one Chemical compound CC#CC1=CNC(=O)N=C1N QNNARSZPGNJZIX-UHFFFAOYSA-N 0.000 description 1
LOSIULRWFAEMFL-UHFFFAOYSA-N 7-deazaguanine Chemical compound O=C1NC(N)=NC2=C1CC=N2 LOSIULRWFAEMFL-UHFFFAOYSA-N 0.000 description 1
HRYKDUPGBWLLHO-UHFFFAOYSA-N 8-azaadenine Chemical compound NC1=NC=NC2=NNN=C12 HRYKDUPGBWLLHO-UHFFFAOYSA-N 0.000 description 1
LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 1
229960005508 8-azaguanine Drugs 0.000 description 1
MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
108700001666 APC Genes Proteins 0.000 description 1
208000004998 Abdominal Pain Diseases 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
102100027211 Albumin Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
108700028369 Alleles Proteins 0.000 description 1
102100021253 Antileukoproteinase Human genes 0.000 description 1
240000003291 Armoracia rusticana Species 0.000 description 1
235000011330 Armoracia rusticana Nutrition 0.000 description 1
102000029330 CSK Tyrosine-Protein Kinase Human genes 0.000 description 1
108010069682 CSK Tyrosine-Protein Kinase Proteins 0.000 description 1
241000244202 Caenorhabditis Species 0.000 description 1
102100031077 Calcineurin B homologous protein 3 Human genes 0.000 description 1
102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
108090000617 Cathepsin G Proteins 0.000 description 1
102000004173 Cathepsin G Human genes 0.000 description 1
239000004380 Cholic acid Substances 0.000 description 1
108090000317 Chymotrypsin Proteins 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
206010055114 Colon cancer metastatic Diseases 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
102100030708 GTPase KRas Human genes 0.000 description 1
102100039788 GTPase NRas Human genes 0.000 description 1
206010051066 Gastrointestinal stromal tumour Diseases 0.000 description 1
206010051922 Hereditary non-polyposis colorectal cancer syndrome Diseases 0.000 description 1
101000777270 Homo sapiens Calcineurin B homologous protein 3 Proteins 0.000 description 1
101000914326 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 6 Proteins 0.000 description 1
101000634974 Homo sapiens E3 ubiquitin-protein ligase TRIM31 Proteins 0.000 description 1
101000744505 Homo sapiens GTPase NRas Proteins 0.000 description 1
101000606465 Homo sapiens Inactive tyrosine-protein kinase 7 Proteins 0.000 description 1
101100222815 Hordeum vulgare EPB2 gene Proteins 0.000 description 1
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
208000022559 Inflammatory bowel disease Diseases 0.000 description 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
102100034343 Integrase Human genes 0.000 description 1
102000004016 L-Type Calcium Channels Human genes 0.000 description 1
108090000420 L-Type Calcium Channels Proteins 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
206010025323 Lymphomas Diseases 0.000 description 1
108010076502 Matrix Metalloproteinase 11 Proteins 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
208000005927 Myosarcoma Diseases 0.000 description 1
101150098207 NAAA gene Proteins 0.000 description 1
108010077850 Nuclear Localization Signals Proteins 0.000 description 1
208000008589 Obesity Diseases 0.000 description 1
REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
102000043276 Oncogene Human genes 0.000 description 1
108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
206010036790 Productive cough Diseases 0.000 description 1
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
108010021833 Proto-Oncogene Proteins c-yes Proteins 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
238000011529 RT qPCR Methods 0.000 description 1
241000700159 Rattus Species 0.000 description 1
108060006706 SRC Proteins 0.000 description 1
102000001332 SRC Human genes 0.000 description 1
241000235070 Saccharomyces Species 0.000 description 1
108010082545 Secretory Leukocyte Peptidase Inhibitor Proteins 0.000 description 1
102000017303 Stromelysin-3 Human genes 0.000 description 1
UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
WFWLQNSHRPWKFK-UHFFFAOYSA-N Tegafur Chemical group O=C1NC(=O)C(F)=CN1C1OCCC1 WFWLQNSHRPWKFK-UHFFFAOYSA-N 0.000 description 1
102100026231 Translocon-associated protein subunit alpha Human genes 0.000 description 1
101710112880 Translocon-associated protein subunit alpha Proteins 0.000 description 1
108010023649 Tripartite Motif Proteins Proteins 0.000 description 1
102000011408 Tripartite Motif Proteins Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
206010064390 Tumour invasion Diseases 0.000 description 1
102100021788 Tyrosine-protein kinase Yes Human genes 0.000 description 1
102100032575 Voltage-dependent L-type calcium channel subunit alpha-1D Human genes 0.000 description 1
101710088841 Voltage-dependent L-type calcium channel subunit alpha-1D Proteins 0.000 description 1
RLXCFCYWFYXTON-JTTSDREOSA-N [(3S,8S,9S,10R,13S,14S,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-16-yl] N-hexylcarbamate Chemical group C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC(OC(=O)NCCCCCC)[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RLXCFCYWFYXTON-JTTSDREOSA-N 0.000 description 1
210000000683 abdominal cavity Anatomy 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
XVIYCJDWYLJQBG-UHFFFAOYSA-N acetic acid;adamantane Chemical compound CC(O)=O.C1C(C2)CC3CC1CC2C3 XVIYCJDWYLJQBG-UHFFFAOYSA-N 0.000 description 1
230000001919 adrenal effect Effects 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
125000005600 alkyl phosphonate group Chemical group 0.000 description 1
150000001408 amides Chemical group 0.000 description 1
125000004103 aminoalkyl group Chemical group 0.000 description 1
230000003321 amplification Effects 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
238000013528 artificial neural network Methods 0.000 description 1
230000037429 base substitution Effects 0.000 description 1
210000002469 basement membrane Anatomy 0.000 description 1
229960000074 biopharmaceutical Drugs 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
230000005907 cancer growth Effects 0.000 description 1
230000009400 cancer invasion Effects 0.000 description 1
231100000504 carcinogenesis Toxicity 0.000 description 1
230000021164 cell adhesion Effects 0.000 description 1
230000004700 cellular uptake Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
235000019416 cholic acid Nutrition 0.000 description 1
229960002471 cholic acid Drugs 0.000 description 1
229960002376 chymotrypsin Drugs 0.000 description 1
210000004922 colonic epithelial cell Anatomy 0.000 description 1
238000010835 comparative analysis Methods 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
125000000753 cycloalkyl group Chemical group 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
238000000326 densiometry Methods 0.000 description 1
KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
238000010511 deprotection reaction Methods 0.000 description 1
238000011033 desalting Methods 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
239000000032 diagnostic agent Substances 0.000 description 1
229940039227 diagnostic agent Drugs 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
238000009826 distribution Methods 0.000 description 1
NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000003596 drug target Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
229940011871 estrogen Drugs 0.000 description 1
239000000262 estrogen Substances 0.000 description 1
238000009541 flexible sigmoidoscopy Methods 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
230000006870 function Effects 0.000 description 1
201000011243 gastrointestinal stromal tumor Diseases 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
125000003827 glycol group Chemical group 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
125000005842 heteroatom Chemical group 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
102000046810 human CEACAM6 Human genes 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
210000002865 immune cell Anatomy 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
201000004933 in situ carcinoma Diseases 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
208000003243 intestinal obstruction Diseases 0.000 description 1
206010022694 intestinal perforation Diseases 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
239000003446 ligand Substances 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
150000002632 lipids Chemical group 0.000 description 1
239000002502 liposome Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
201000005202 lung cancer Diseases 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
210000004880 lymph fluid Anatomy 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
230000025608 mitochondrion localization Effects 0.000 description 1
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
201000002077 muscle cancer Diseases 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
235000020824 obesity Nutrition 0.000 description 1
210000003463 organelle Anatomy 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000037361 pathway Effects 0.000 description 1
ONTNXMBMXUNDBF-UHFFFAOYSA-N pentatriacontane-17,18,19-triol Chemical compound CCCCCCCCCCCCCCCCC(O)C(O)C(O)CCCCCCCCCCCCCCCC ONTNXMBMXUNDBF-UHFFFAOYSA-N 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
150000002978 peroxides Chemical class 0.000 description 1
239000003614 peroxisome proliferator Substances 0.000 description 1
150000004713 phosphodiesters Chemical class 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
150000008298 phosphoramidates Chemical class 0.000 description 1
210000002381 plasma Anatomy 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920000768 polyamine Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
102000054765 polymorphisms of proteins Human genes 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
239000002987 primer (paints) Substances 0.000 description 1
210000002307 prostate Anatomy 0.000 description 1
108020001580 protein domains Proteins 0.000 description 1
238000000746 purification Methods 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
206010038038 rectal cancer Diseases 0.000 description 1
201000001275 rectum cancer Diseases 0.000 description 1
238000009877 rendering Methods 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
238000003757 reverse transcription PCR Methods 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
238000003345 scintillation counting Methods 0.000 description 1
230000028327 secretion Effects 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
210000001599 sigmoid colon Anatomy 0.000 description 1
239000011734 sodium Substances 0.000 description 1
210000003802 sputum Anatomy 0.000 description 1
208000024794 sputum Diseases 0.000 description 1
230000004960 subcellular localization Effects 0.000 description 1
IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical group NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
150000003456 sulfonamides Chemical group 0.000 description 1
BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
150000003457 sulfones Chemical group 0.000 description 1
150000003462 sulfoxides Chemical class 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
150000003568 thioethers Chemical class 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
206010044412 transitional cell carcinoma Diseases 0.000 description 1
230000000472 traumatic effect Effects 0.000 description 1
238000011269 treatment regimen Methods 0.000 description 1
ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 1
JQZIKLPHXXBMCA-UHFFFAOYSA-N triphenylmethanethiol Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(S)C1=CC=CC=C1 JQZIKLPHXXBMCA-UHFFFAOYSA-N 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
239000000107 tumor biomarker Substances 0.000 description 1
125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
239000013598 vector Substances 0.000 description 1
210000000504 visceral peritoneum Anatomy 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
238000004804 winding Methods 0.000 description 1
229940075420 xanthine Drugs 0.000 description 1